Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol DEK contributors: mct/pgu - updated : 07-02-2018
HGNC name DEK oncogene
HGNC id 2768
PROTEIN
PHYSICAL PROPERTIES acid
STRUCTURE
motifs/domains
  • a SAP putative DNA binding domain
  • an acidic domain interacting with histone
  • central and C-terminal regions are highly conserved
  • conjugated PhosphoP
    HOMOLOGY
    interspecies ortholog to rattus Dek (92.5 pc)
    ortholog to murine Dek (91.4 pc)
    Homologene
    FAMILY
  • DNA-binding SAP family
  • CATEGORY chaperone/stress , protooncogene
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus,nucleoplasm
    basic FUNCTION
  • playing a role in viral genome replication
  • inducing positive supercoils into closed circular DNA
  • being also involved in splice site selection during mRNA processing
  • nuclear phosphoprotein implicated in oncogenesis and autoimmunity
  • promotes the repair of DNA lesions and protects cells from genotoxic agents that typically trigger poly(ADP-ribose) polymerase activation
  • crucial role of poly(ADP-ribosyl)ation in shaping DEK autoantigenic properties and in its function as a promoter of cell survival
  • suppresses cellular senescence, apoptosis, and differentiation, thus promoting cell growth and survival in monolayer and organotypic epithelial raft models
  • required for intron removal
  • exerting a potent inhibitory effect on both EP300 and PCAF-mediated histone acetyltransferase activity and transcription
  • playing a role in the proliferation of hematopoietic cells
  • DEK-NUP214 fusion protein appears defective, at least in part, in assisting transcriptional regulation of certain genes that might be essential for normal differentiation of hematopoietic cells
  • may be a histone chaperone
  • promotes leukemic cell survival and is downregulated by both Nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells
  • DEK positively regulates engrafting capability of self-renewing hematopoietic stem (HSCs)
  • CEBPA and DEK coordinately activate myeloid gene expression and S21 phosphorylation on wild-type CEBPA mediates protein interactions that regulate the differentiation capacity of hematopoietic progenitors
  • biochemically distinct, conserved nonhistone protein that is vital to global heterochromatin integrity
  • paracrine loop involving DEK plays a role in chromatin biology
  • identified as one of the most abundant proteins in human chromatin
  • is a unique chromatin architectural factor which binds to non-B-form DNA structures, such as cruciform DNA or four-way junctions
  • facilitates cellular proliferation under conditions of DNA replication stress by promoting replication fork progression
  • plays an important role in cell processes and participates in a variety of cellular metabolic functions, and its altered expression is associated with several human malignancies
  • critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma
  • transcription factor, involved in mRNA splicing, transcriptional control, cell division and differentiation
  • important for DNA double-strand break repair
  • plays multiple roles to facilitate tumor growth and maintenance
  • CELF1 and DEK were found to represent early-induced melanoma genes and adverse indicators of overall patient survival
  • CELLULAR PROCESS nucleotide, transcription, regulation
    nucleotide, RNA splicing
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling signal transduction
    a component
  • found in a mRNA splicing-dependent exon junction complex (EJC) with DEK, RBM8A, RNPS1, SRRM1 and THOC4
  • INTERACTION
    DNA binding to cruciform and superhelical DNA
    RNA binding
    small molecule nucleotide,
  • GTP
  • protein
  • histones H2A, H2B, H3, H4, acetylated histone H4
  • non-phosporylated DAXX
  • HDAC2
  • interacting wth SET and PARP1 (constitute a network governing access to chromatin by the transcription machinery)
  • molecular links between DEK and DNA damage response signaling pathways, suggesting that DEK contributes to DNA repair
  • DEK emerges as an TERT repressor shared by various leukemia subtypes and seems involved in the deregulation of numerous genes associated with leukemogenesis
  • is a critical factor that interacts with an essential upstream enhancer element of the KLF1 promoter and exerts a positive effect on KLF1 levels
  • DEK is an unexpected target and downstream effector of CELF1
  • cell & other
  • the (pets) site of the HIV2 enhancer, autoantigen in patients with pauciarticular onset juvenile rheumatoid arthritis
  • REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) DEK
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in hepatocellular carcinoma
    tumoral     --over  
    in many solid tumors such as colon cancer, larynx cancer, bladder cancer, and melanoma
    tumoral fusion translocation    
    t(6;9) chromosomal translocation associated with a subtype of acute myelogenous leukemia (AML), which results in the formation of a DEK-NUP214 fusion protein
    tumoral     --over gain of function
    in retinoblastoma
    tumoral     --over  
    overexpression in pancreatic ductal adenocarcinoma (PDAC) was correlated with tumor size, histological grade, tumor&8209;node&8209;metastasis (TNM) stage and overall survival (OS) rates
    Susceptibility
    Variant & Polymorphism
    Candidate gene
  • detection of DEK protein expression should be useful for the diagnosis and prognosis of ovarian serous cancer
  • may be a potential biomarker for poor prognostic evaluation in PDAC
  • Marker
    Therapy target
    SystemTypeDisorderPubmed
    neurologyataxia 
    able to partially reverse the mutation-prone phenotype of cells from patients with ataxia telangiectasia
    cancerreproductiveovary
    might be a useful molecular target for ovarian cancer therapy
    cancer  
    targeted suppression of DEK may become a strategic approach to the treatment of cancer
    cancerbrain 
    can be used as a potential target for astrocytic tumor gene therapy
    ANIMAL & CELL MODELS